Evidence map›Paper›PMID 32351910›Full record

ArticleInternational journal of molecular and cellular medicine2019

Association Analysis of the HNF4A Common Genetic Variants with Type 2 Diabetes Mellitus Risk.

Seyedeh Mina Azizi, Negar Sarhangi, Mahdi Afshari, Davood Abbasi, Hamid Reza Aghaei Meybodi, Mandana Hasanzad

Open access · greenAbstract read
In one paragraph

Article in International journal of molecular and cellular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. MODY Only Monogenic? A Narrative Review of theInternational journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Artificial intelligence perspective in the future of endocrine diseases.Journal of diabetes and metabolic disorders · 2022
    Review
  8. Maturity Onset Diabetes of the Young-New Approaches for Disease Modelling.International journal of molecular sciences · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Seyedeh Mina AziziMedical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Negar SarhangiPersonalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mahdi AfshariDepartment of Community Medicine, Zabol University of Medical Sciences, Zabol, Iran.
Davood AbbasiIranian Diabetes Society, Eslamshahr Branch, Iran.
Hamid Reza Aghaei MeybodiPersonalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mandana HasanzadMedical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Tehran University of Medical Sciences · IRIslamic Azad University Medical Branch of Tehran · IRZabol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is a complex disease that involves a wide range of genetic and environmental factors. The

Indexed as

geneHNF4AsequencingT2DMT2DM complication

Identifiers

PMID32351910
PMCPMC7175614
OpenAlexW3007971971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.